{
    "id": 26812,
    "cites": 111,
    "cited_by": 2,
    "reference": [
        "Adams, Jerome, Gregory H. Bledsoe, and John H. Armstrong. \"Are pain management questions in patient satisfaction surveys driving the opioid epidemic?\" American Journal of Public Health 106 (2016): 985.",
        "Alpert, Abby, David Powell, and Rosalie Liccardo Pacula. \"Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids.\" American Economic Journal: Economic Policy 10 (2018): 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c35.",
        "Al-Tayyib, Alia A., Stephen Koester, and Paula Riggs. \"Prescription opioids prior to injection drug use: Comparisons and public health implications.\" Addictive behaviors 65 (2017): 224\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c228.",
        "Arkes, Jeremy, Rosalie Liccardo Pacula, Susan M. Paddock, Jonathan P. Caulkins, and Peter Reuter. \"Why the DEA Stride data are still useful for understanding drug markets.\" National Bureau of Economic Research, no. 14224 (August 2008).",
        "Bambauer, Kara Zivin, James E. Sabin, and Stephen B. Soumerai. \"The exclusion of benzodiazepine coverage in Medicare: simple steps for avoiding a public health crisis.\" Psychiatric Services 56 (2005): 1143\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1146.",
        "Becker, Gary S. \"Irrational behavior and economic theory.\" Journal of political economy 70 (1962): 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c13.",
        "Becker, Gary S., and Kevin M. Murphy. \"A Theory of Rational Addiction.\" Journal of Political Economy 96, no. 4 (August 1988): 675-700.",
        "Becker, Gary S., Kevin M. Murphy, and Michael Grossman. \"The Market for Illegal Goods: The Case of Drugs.\" Journal of Political Economy 114, no. 1 (February 2006): 38\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c60.",
        "Boards of Trustees, Federal Hospital Insurance and Federal Supplementantal Medicare Insurance Trust Funds. \"2014 Annual Report.\" 2014.",
        "Boards of Trustees, Federal Hospital Insurance and Federal Supplementantal Medicare Insurance Trust Funds. \"2019 Annual Report.\" 2019. Breslow, Jason M. \"Eric Holder: If Sentencing Reform Dies, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093I\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2d Be Ashamed\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d.\" pbs.org.",
        "Buchmueller, Thomas C., and Colleen Carey. \"The effect of prescription drug monitoring programs on opioid utilization in Medicare.\" American Economic Journal: Economic Policy 10 (2018): 77\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c112.",
        "Butterfield, Fox. \"Theft of Painkiller Reflects Its Popularity on the Street.\" New York Times, July 7, 2001.",
        "Cartwright, David T. Dark Paradise: A History of Opiate Addiction in America. Cambridge, MA: Harvard University Press, 2001.",
        "Case, Anne, and Angus Deaton. \"Mortality and morbidity in the 21st century.\" Brookings papers on economic activity 2017 (2017): 397\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c476.",
        "Caulkins, Jonathan P., Beau Kilmer, Peter H. Reuter, and Greg Midgette. \"Cocaine&apos;s fall and marijuana&apos;s rise: questions and insights based on new estimates of consumption and expenditures in US drug markets.\" Addiction 110 (2015): 728\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c736.",
        "Centers for Disease Control and Prevention. \"CDC compilation of benzodiazepines, muscle relaxants, stimulants, zolpidem, and opioid analgesics with oral morphine milligram equivalent conversion factors.\" cdc.gov. September 2018. https://www.cdc.gov/drugoverdose/datafiles /CDC_Oral_Morphine_Milligram_Equivalents_Sept_2018.xlsx.",
        "Centers for Medicare and Medicaid Services. \"Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs.\" Federal Register, November 21, 2018: 59147-59179.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Medicare Program: Medicare Prescription Drug Benefit.\" Federal Register, January 28, 2005: 4194-4585.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Medicare Program; Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2013 and Other Changes.\" Federal Register, April 2012: 22072-22175.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"HCAHPS Fact Sheet.\" hcahpsonline.org. November 2017. https://www.hcahpsonline.org/globalassets/hcahps/facts/hcahps_fact_sheet_november_20 17.pdf.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"HCAHPS Update Training.\" cms.gov. February 2019. HCAHPS Update Training.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Medicaid State Opioid Prescribing Mapping Tool.\" CMS.gov. May 1, 2019a. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-andReports /Medicare-Provider-Charge-Data/OpioidMap_Medicaid_State.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Medicare Part D Opioid Prescribing Mapping Tool.\" CMS.gov. May 1, 2019b. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-andReports /Medicare-Provider-Charge-Data/OpioidMap_Medicare_PartD.",
        "Chicago Tribune Editors. \"Drug lab shut down.\" Chicago Tribune, June 6, 2006.",
        "Ciccarone, Daniel, Jeff Ondocsin, and Sarah G. Mars. \"Heroin uncertainties: Exploring users\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 perceptions of fentanyl-adulterated and-substituted \u00c3\u00a2\u00e2\u0082\u00ac\u00cb\u009cheroin\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2.\" International Journal of Drug Policy 46 (2017): 146\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c155.",
        "Cicero, Theodore J., Matthew S. Ellis, and Zachary A. Kasper. \"Increased use of heroin as an initiating opioid of abuse.\" Addictive behaviors 74 (2017): 63\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c66.",
        "Cicero, Theodore J., Matthew S. Ellis, Hilary L. Surratt, and Steven P. Kurtz. \"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.\" JAMA psychiatry 71 (2014): 821\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c826.",
        "Congressional Research Service. \"Scheduling of Fentanyl Analogues: The New Legal Landscape.\" crsreports.congress.gov. February 7, 2020. https://crsreports.congress.gov/product/pdf/LSB/LSB10404. Council of Economic Advisers. The Role of Opioid Prices in the Evolving Opioid Crisis.",
        "Executive Office of the President, April 2019.",
        "Council of Economic Advisers. The Underestimated Cost of the Opioid Crisis. Executive Office of the President, October 2019.",
        "Dasgupta, Nabarun, et al. \"Crowdsourcing black market prices for prescription opioids.\" Journal of Medical Internet Research 15 (2013): e178.",
        "Department of Health and Human Services, Office of the Inspector General. \"Opioid Use Decreased in Medicare Part D, While Medication-Assisted Treatment Increased.\" oig.hhs.gov. July 2019. Opioid Use Decreased in Medicare Part D, While .",
        "Department of Justice. \"DEA Heads First-ever Nationwide Prescription Drug Take-back Day.\" justice.gov. August 19, 2010. https://www.justice.gov/opa/pr/dea-heads-first-evernationwide -prescription-drug-take-back-day.",
        "Department of Veterans Affairs. \"Pain as the 5th vital sign toolkit.\" Washington, DC: Department of Veterans Affairs, 2000.",
        "Diamond, Peter A., and James A. Mirrlees. \"Optimal taxation and public production I: Production efficiency.\" The American Economic Review 61 (1971): 8\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c27.",
        "Doleac, Jennifer L., and Anita Mukherjee. \"The moral hazard of lifesaving innovations: naloxone access, opioid abuse, and crime.\" IZA Discussion Paper Series, no. 11489 (April 2018).",
        "Drug Enforcement Administration. \"DEA National Rx Takeback.\" takebackday.dea.gov. 2020. https://takebackday.dea.gov/.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"DEA Warning To Police And Public: Fentanyl Exposure Kills.\" dea.gov. June 10, 2016. https://www.dea.gov/press-releases/2016/06/10/dea-warning-police-and-public-fentanylexposure -kills.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II.\" Federal Register, August 22, 2014: 49661-49682.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"National drug threat assessment (2018).\" dea.gov. October 2018.",
        "Egan, Kathleen L., Eric Gregory, Michael Sparks, and Mark Wolfson. \"From dispensed to disposed: evaluating the effectiveness of disposal programs through a comparison with prescription drug monitoring program data.\" The American journal of drug and alcohol abuse 43 (2017): 69\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c77.",
        "Einav, Liran, Amy Finkelstein, and Paul Schrimpf. \"The response of drug expenditure to nonlinear contract design: Evidence from Medicare Part D.\" The Quarterly Journal of Economics 130 (2015): 841\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c899.",
        "Evans, William N., Ethan M. J. Lieber, and Patrick Power. \"How the reformulation of OxyContin ignited the heroin epidemic.\" Review of Economics and Statistics 101 (2019): 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c15.",
        "Express Scripts. \"2018 Drug Trend Report.\" express-scripts.com. February 6, 2019. https://web.archive.org/web/20191216173635/https://www.expressscripts. com/corporate/drug-trend-report.",
        "Farrell, Graham, Kashfia Mansur, and Melissa Tullis. \"Cocaine and heroin in europe 1983\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c93: a cross-national comparison of trafficking and prices.\" The British Journal of Criminology 36 (1996): 255\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c281.",
        "Federal Bureau of Prisons. \"Past Inmate Population Totals.\" bop.gov. January 9, 2020. https://www.bop.gov/about/statistics/population_statistics.jsp.",
        "Food and Drug Administration. \"Abuse-Deterrent Opioid Analgesics.\" fda.gov. June 11, 2019a. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-andproviders /abuse-deterrent-opioid-analgesics.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"FDA analysis of long-term trends in prescription opioid analgesic products: quantity, sales, and price trends.\" fda.gov. March 1, 2018. https://www.fda.gov/media/111695/download.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"FDA Drug Safety Communication: FDA recommends against the continued use of propoxyphene.\" fda.gov. November 19, 2010. https://www.fda.gov/drugs/drug-safetyand -availability/fda-drug-safety-communication-fda-recommends-against-continued-usepropoxyphene.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Safety Labeling Change Notification.\" fda.gov. August 21, 2016. https://www.fda.gov/media/99689/download.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Statement on agency\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s first year accomplishments implementing SUPPORT Act authorities to address the opioids crisis.\" fda.gov. October 14, 2019b. https://www.fda.gov/news50 events/press-announcements/statement-agencys-first-year-accomplishmentsimplementing -support-act-authorities-address-opioids.",
        "Frank, Richard G., and Harold A. Pollack. \"Addressing the fentanyl threat to public health.\" New England journal of medicine 376 (2017): 605\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c607. Friedman, Milton. \"The Methodology of Positive Economics.\" In Essays in Positive Economics.",
        "Gallet, Craig A. \"Can price get the monkey off our back? A meta-analysis of illicit drug demand.\" Health economics 23 (2014): 55\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c68.",
        "Good, Bernie. \"Federal Healthcare System Experience: VA Implementation, Maintenance, and Evaluation.\" fda.gov. May 2017. https://www.fda.gov/media/105295/download. Governor\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Task Force on Drug Enforcement, Treatment, and Prevention. \"Final Report.\" in.gov.",
        "Harberger, Arnold C. \"Monopoly and Resource Allocation.\" American Economic Review, 5 1954.",
        "Hempstead, Katherine, and Emel O. Yildirim. \"Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey.\" Health economics 23 (2014): 688\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c705.",
        "Henden, Edmund, Hans-Olav Melberg, and Ole Rogeberg. \"Addiction: choice or compulsion?\" Frontiers in psychiatry 4 (2013): 77.",
        "Higham, Scott, Sari Horwitz, and Katie Zezima. \"The Fentanyl Failure.\" The Washington Post, March 13, 2019. Hingson, Ralph, and Donald Kenkel. \"Social, Health, and Economic Consequences of Underage Drinking.\" In Reducing underage drinking: A collective responsibility, by Richard J.",
        "Hirsch, Anne, Scott K. Proescholdbell, William Bronson, and Nabarun Dasgupta. \"Prescription histories and dose strengths associated with overdose deaths.\" Pain medicine 15 (2014): 1187\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1195.",
        "Holder, Eric. \"Department Policy on Charging Mandatory Minimum Sentences and Recidivist Enhancements in Certain Drug Cases.\" justice.gov. August 12, 2013. https://www.justice.gov/sites/default/files/oip/legacy/2014/07/23/ag-memo-departmentpolicypon -charging-mandatory-minimum-sentences-recidivist-enhancements-in-certaindrugcases. pdf.",
        "Jacques, Scott, Andrea Allen, and Richard Wright. \"Drug dealers\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 rational choices on which customers to rip-off.\" International Journal of Drug Policy 25 (2014): 251\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c256.",
        "Jaffe, Sonia, Robert Minton, Casey B. Mulligan, and Kevin M. Murphy. Chicago Price Theory. Princeton University Press (ChicagoPriceTheory.com), 2019.",
        "Japsen, Bruce. \"Amid Opioid Crisis, The Joint Commission Revises Pain Management Standards.\" Forbes, January 3, 2019.",
        "Jayawant, Sujata S., and Rajesh Balkrishnan. \"The controversy surrounding OxyContin abuse: issues and solutions.\" Therapeutics and clinical risk management 1 (2005): 77.",
        "Jena, Anupam B., and Dana P. Goldman. \"Growing Internet use may help explain the rise in prescription drug abuse in the United States.\" Health affairs 30 (2011): 1192\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1199.",
        "Johnson, Timothy, and Michael Fendrich. \"Modeling sources of self-report bias in a survey of drug use epidemiology.\" Annals of epidemiology 15 (2005): 381\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c389.",
        "Joint Commission on Accreditation of Healthcare Organizations. \"Joint Commission on Accreditation of Healthcare Organizations Pain Standards for 2001.\" jointcommission.org. December 18, 2001. https://www.jointcommission.org/sitecore/media-library/tjc/documents/resources/painmanagement /2001_pain_standardspdf/.",
        "Lohr, K. Medicare: A strategy for quality assurance. Volume 1: Report of a study. Washington DC: National Academy Press, 1990.",
        "Lucas, Robert E., Jr. \"Econometric Policy Evaluation: A Critique.\" Carnegie-Rochester Conference Series on Public Policy 1, no. 1 (January 1976): 19-46.",
        "Maust, Donovan T., Lewei A. Lin, Frederic C. Blow, and Steven C. Marcus. \"County and Physician Variation in Benzodiazepine Prescribing to Medicare Beneficiaries by Primary Care Physicians in the USA.\" Journal of general internal medicine 33 (2018): 2180\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 2188.",
        "Morral, Andrew R., Daniel McCaffrey, and Martin Y. Iguchi. \"Hardcore drug users claim to be occasional users: drug use frequency underreporting.\" Drug and alcohol dependence 57 (2000): 193\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c202.",
        "Mulligan, Casey B. The Redistribution Recession. New York: Oxford University Press (redistributionrecession.com), 2012.",
        "Mundkur, Mallika L., et al. \"Days\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 supply of initial opioid analgesic prescriptions and additional fills for acute pain conditions treated in the primary care setting\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dUnited States, 2014.\" Morbidity and Mortality Weekly Report 68 (2019): 140. National Academies of Sciences, Medicine, and others. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use.",
        "National Center for Health Statistics. \"Multiple Cause of Death Data Files.\" cdc.gov. 1999-2018. https://www.cdc.gov/nchs/nvss/deaths.htm.",
        "National Institute on Drug Abuse. \"Benzodiazepines and Opioids.\" drugabuse.gov. March 2018b. https://www.drugabuse.gov/drugs-abuse/opioids/benzodiazepines-opioids.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Opioid Overdose Reversal with Naloxone (Narcan, Evzio).\" drugabuse.gov. April 2018. https://www.drugabuse.gov/related-topics/opioid-overdose-reversal-naloxone-narcanevzio.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Prescription Opioids and Heroin.\" drugabuse.gov. January 2018a. https://www.drugabuse.gov/publications/research-reports/relationship-betweenprescription -drug-heroin-abuse/prescription-opioid-use-risk-factor-heroin-use.",
        "Nguyen, Thuy D., W. David Bradford, and Kosali I. Simon. \"How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs.\" NBER working paper, 10 2019.",
        "Office of National Drug Control Policy. National Drug Control Strategy. Washington, DC: Executive Office of the President, 2020. Office of National Drug Control Policy. What America\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Users Spend on Illegal Drugs, 20002006.",
        "Washington, DC: Executive Office of the President, 2012. Office of National Drug Control Policy. What America\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Users Spend on Illegal Drugs, 20002010.",
        "Washington, DC: Executive Office of the President, 2014. Office of National Drug Control Policy. What America\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Users Spend on Illegal Drugs, 20062016.",
        "Washington, DC: Executive Office of the President, 2019.",
        "Paavola, Alia. \"Top PBMs by Market Share.\" beckershospitalreview.com. May 30, 2019. https://www.beckershospitalreview.com/pharmacy/top-pbms-by-market-share.html.",
        "Pacula, Rosalie Liccardo, and David Powell. \"A Supply-side Perspective on the Opioid Crisis.\" Journal of Policy Analysis and Management 37 (2018): 438\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c446.",
        "Park, Tae Woo, Richard Saitz, Dara Ganoczy, Mark A. Ilgen, and Amy S. B. Bohnert. \"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.\" BMJ 350 (2015): h2698.",
        "Peltzman, Sam. \"The effects of automobile safety regulation.\" Journal of Political Economy 83 (1975): 677\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c725.",
        "Perron, Pierre. \"Dealing with structural breaks.\" Palgrave handbook of econometrics 1 (2006): 278\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c352. Physicians for Responsible Opioid Prescribing. \"Citizen Petition to the Centers for Medicare and Medicaid Services (CMS) requesting changes to the HCAHPS Survey.\" supportprop.org.",
        "Pollak, Robert A. \"Habit formation and dynamic demand functions.\" Journal of political Economy 78 (1970): 745\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c763.",
        "Powell, David, Rosalie Liccardo Pacula, and Erin Taylor. \"How increasing medical access to opioids contributes to the opioid epidemic: evidence from medicare part d.\" Paper presented at the 2017 Meetings of the National Tax Association, April 2017.",
        "President&apos;s Commission on Combating Drug Addiction and the Opioid Crisis. \"Final Report.\" whitehouse.gov. November 1, 2017.",
        "Quinones, Sam. Dreamland: The true tale of America&apos;s opiate epidemic. New York: Bloomsbury Publishing USA, 2015.",
        "Reuter, Peter, and Mark A. R. Kleiman. \"Risks and prices: An economic analysis of drug enforcement.\" Crime and justice 7 (1986): 289\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c340.",
        "Rhodes, Emily, Maria Wilson, Alysia Robinson, Jill A. Hayden, and Mark Asbridge. \"The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.\" BMC health services research 19 (2019): 784. Roehrig, Charles. The impact of prescription drug rebates on health plans and consumers.",
        "Ruhm, Christopher J. \"Drivers of the fatal drug epidemic.\" Journal of health economics 64 (2019): 25\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c42.",
        "Savona, Ernesto U., Mark A. R. Kleiman, and Francesco Calderoni. Dual Markets: Comparative Approaches to Regulation. Cham, Switzerland: Springer, 2017.",
        "Schnell, Molly. \"The Economics of Physician Behavior.\" Princeton University PhD Dissertation, 2018.",
        "Sessions, Jeff. \"Department Charging and Sentencing Policy.\" justice.gov. May 10, 2017. https://www.justice.gov/opa/press-release/file/965896/download.",
        "Soni, Aparna. \"Health Insurance, Price Changes, and the Demand for Pain Relief Drugs: Evidence from Medicare Part D.\" Kelley School of Business Research Paper, 2018.",
        "Stehr, Mark. \"Cigarette tax avoidance and evasion.\" Journal of health economics 24 (2005): 277\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c297.",
        "Sun, Eric C., Anjali Dixit, Keith Humphreys, Beth D. Darnall, Laurence C. Baker, and Sean Mackey. \"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.\" BMJ 356, no. 8097 (March 2017).",
        "Taitel, Michael, Leonard Fensterheim, Heather Kirkham, Ryan Sekula, and Ian Duncan. \"Medication days&apos; supply, adherence, wastage, and cost among chronic patients in Medicaid.\" Medicare & Medicaid Research Review 2 (2012).",
        "\"The Patient Protection and Affordable Care Act.\" Public Law 148, March 23, 2010.",
        "TrueMedCost.com. \"Oxycontin Price.\" truemedcost.com. July 2014. https://web.archive.org/web/20140729165538/https:/www.truemedcost.com/oxycontinprice /. U.S. Department of Justice. \"Fentanyl Situation Report.\" justice.gov. June 5, 2006. https://www.justice.gov/archive/ndic/pubs11/20469/index.htm. \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"One Year After Launching Key Sentencing Reforms, Attorney General Holder Announces First Drop in Federal Prison Population in More Than Three Decades.\" justice.gov.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Smart on Crime.\" justice.gov. August 2013. https://www.justice.gov/sites/default/files/ag/legacy/2013/08/12/smart-on-crime.pdf.",
        "\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d. \"Statement of the Department of Justice Before the United States Senate Committee on the Judiciary For a Hearing Entitled \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Countdown :Fentanyl Analogues & the Expiring Emergency Scheduling Order\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d.\" June 4, 2019. https://www.dea.gov/sites/default/files/201906 /DOJ%20DEA%20Fentanyl%20Expiration%20of%20Temp%20Order_SJC_4June19_ final.pdf.",
        "U.S. Department of Justice, Office of the Inspector General. \"Review of the Department\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Implementation of Prosecution and Sentencing Reform Principles under the Smart on Crime Initiative.\" oig.justice.gov. June 2017. https://oig.justice.gov/reports/2017/e1704.pdf.",
        "United Nations Office on Drugs and Crime. \"Standardized prices of cocaine and heroin in the United States and Western Europe.\" In World Drug Report 2018. Vienna: United Nations, 2018.",
        "United States Government Accountability Office. Progress Made Towards Improving Opioid Safety, but Further Efforts to Assess Progress and Reduce Risk Are Needed. Report to Congressional Committees, Washington, DC: United States Government Accountability Office, 2018.",
        "Wikipedia. \"Equianalgesic.\" wikipedia.org. 2020. https://en.wikipedia.org/wiki/Equianalgesic.",
        "Wilkie, Robert. \"Fighting pain and addiction for veterans.\" Newsday, October 25, 2018.",
        "Zhou, Chao, Curtis S. Florence, and Deborah Dowell. \"Payments for opioids shifted substantially to public and private insurers while consumer spending declined, 1999\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2012.\" Health affairs 35 (2016): 824\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c831."
    ]
}